The National Centre for Scientific Research is one of the most renowned public research institutions in the world. For more than 80 years, it has met the requirement of excellence in its recruitment and has developed multi and interdisciplinary research throughout the country, in Europe and internationally. Oriented towards the common good, it contributes to France's scientific, economic, social and cultural progress. The CNRS is above all 32,000 men and women and 200 professions. Its 1,000 laboratories, most of which are shared with universities, schools and other research organisations, employ more than 120,000 people; they advance knowledge by exploring life, matter, the universe and the functioning of human societies. The close link between its research activities and their transfer to society makes it a key player in innovation today. The partnership with companies is the basis of its development policy. This is achieved through more than 150 joint structures with industrial players and the creation of around one hundred start-ups each year, demonstrating the economic potential of its research work. CNRS makes research work and data accessible; this knowledge sharing targets different audiences: scientific communities, media, decision-makers, economic players and the general public.

The CNRS is multidisciplinary and covers all scientific fields: human and social sciences, biology, nuclear and particle physics, information sciences, engineering and systems sciences, physics, mathematics, chemistry, earth and universe sciences, ecology and the environment.

Imitation of structures, properties, processes and interactions developed by biological entities, achievements inspired by nature are increasingly widespread in many fields of research and innovation. The CNRS Institute of Engineering and Systems Sciences has thus chosen Nature-inspired Engineering as its priority scientific theme for 2020. Researchers from its laboratories will show at Biomimexpo how models in nature can be a factor of inspiration for finding engineering solutions to an identified and formalised scientific and/or technological problem.

For more information: and



Pink Innov' is a network of women and men involved in innovation. Its ambition is to explain, illustrate and bring innovation to life by facilitating its concrete application in companies.

We observe current events, contribute our thoughts, encourage exchanges and organise practical workshops to build innovation in a maker spirit.

We provide our members with pragmatic answers through international academic monitoring, conferences on start-ups and large groups, feedback and immersive case studies to put innovation into practice.

Pink Innov' and Biomim'expo :

Pink Innov' is delighted to announce its partnership with Biomim'expothe great gathering of biomimicry and bio-inspired innovations.

  • How does nature inspire tomorrow's innovations and provide solutions to our contemporary challenges?
  • How are all sectors affected?

Biomimicry is a real opportunity for the future, and is a fast-growing approach, at the heart of the innovation strategies of many companies, research centres and innovative businesses, because it is at the heart of the new transition underway: saving energy; producing less waste; combining growth and biodiversity; working and communicating in open, collegial systems; distorting thinking to innovate through decompartmentalized approaches, inspired by the 3.8 billion years of R&D in the living world!

Pink Innov', more than ever, is part of the process of inventing tomorrow's world with and through living organisms and participating in the exploration of biomimicry and bio-inspiration "Explains Hélène Campourcy, Founder and President of Pink Innov'.

Let's meet for this beautiful event on 20 October 2020.



Hélène Campourcy /



In 2019, the Ceebios, makesense and NewCorp Consulting have together created the Biom'impact tour, first tour of France for the emergence of biomimetic projects with impact !

The tour was supported by the New Aquitaine Regionthe Southern Region, TEN and L'Oréal.

Rationale and objectives :

Biomimicry is the act of be inspired by nature to meet the challenges of our societies! This is just common sense, when you think that she had almost 4 billion years for innovatemake mistakesand select what works bestin all areas!

The aim is to mix biomimicry and entrepreneurship social to generate biomimetic projects à impact and inspire each to to orientate oneself to this sector.

From 8 June to 5 July 2019, 150 participants registered for the online CREATHON! 4 weeks of collective work to create impactful team projects inspired by life! More than 20 projects were born, some of which participated in the Biomim'Challenge 2020.



Phil Becquet /



The association Fermes d'Avenir wishes to bring together, publicise and defend the interests of farms that are meeting the current agricultural and food challenges. Driven by the general interest, they allow to feeding the population with healthy and quality food (taste, maturity...), by preserving the planet's natural capital (water, soil, climate, biodiversity...) and by ensuring a viable, livable and resilient business for farmers.

The association proposes to farms that recognize themselves in our vision to be part of the Network of Farms of the Future"., a community of farms committed to an agroecological approach. This network aims to bring together all those who are committed to progress in agro-ecology, whether it be in the context of a new installation, a step-by-step reorientation of their farm or an already exemplary activity.

Our vision of agroecology :

The mission of Fermes d'Avenir is to accelerate the agricultural transition, by growing agroecological farms all over France.

But what is agroecology? Unlike organic farming, agroecology is not defined by any specifications, so it is not obvious which farm is agroecological and which is not. We simply define agroecological farms as farms that allow the population to be fed with healthy, high-quality food (taste, maturity, etc.), while preserving the planet's natural capital (water, soil, climate, biodiversity, etc.) and guaranteeing a viable, livable and resilient activity for farmers. 

In order to present this vision and definition in an educational way, we have devised a "Flower of Agroecology which highlights the 12 major aspects of this type of production:

More on the website



Professor at the National Museum of Natural History (MNHN)AgroParisTech and ENS. Team "Genetic systems, adaptation & domestication "Laboratory: " Institute of Systematics, Evolution and Biodiversity MNHN-CNRS, UMR 7205, Department of "The Environment". Systematics & Evolution "

Biography page

Pierre-Henri Gouyon is a geneticist and evolution specialist, born on 25 December 1953. He was admitted to Agro (Institut National Agronomique Paris-Grignon, now AgroParisTech) in 1972, became an agricultural engineer in 1975, obtained a post-graduate doctorate in ecology at the University of Montpellier in 1976, then obtained a doctorate in genetics from Agro in 1978, a doctorate in science from the University of Montpellier in 1982 and a DEA in Philosophy at the University of Letters of Montpellier in 1984.

Recruited as a teacher at Agro in 1976, he was a professor at the University of Paris-Sud (Orsay) from 1988 to 2005 and theÉcole Polytechnique from 1994 to 2008 (vice-chair of the Biology Department 2001-2006).

He has held various responsibilities on the Life Sciences Departmental Council of the CNRS (Deputy Scientific Director in 2000-2001). He has been a member of the CNRS operational committee for ethics in the life sciences, the National Council of Universities, the National Committee for Scientific Research, the ANR "Ecosystems and Sustainable Development" committee, the Scientific Council of the CNRS Jacques Monod Lectures and the INSERM ethics committee.

He was managing editor of the Journal of Evolutionary Biology "(1992-1996), journal of the European Society of Evolutionary Biology, co-director of the Master's degree course " Sustainable Agricultural Development"Director of the UPS-CNRS-ENGREF laboratory of "Ecology, Systematics and Evolution "(1997-2005) and head of the botany team within the CNRS-MNHN OSEB UMR (2006-2011).

He is currently a professor at National Museum of Natural History (since 2005), theAgroParisTech (since 1988), in Sciences Po (since 2009) and ENS (since 2012) and carries out his research in the the botany team in the UMR MNHN-CNRS OSEB (7205). He was elected in 2008 to the Academia Europaea (London).

He lectures extensively on issues related to evolution, genetics, ecology, biodiversity and bioethics. He is widely involved in debates concerning science-society relations in general. More particularly, he is concerned on the one hand with the social consequences of the neo-Darwinian theory of evolution on our perception of living beings and on the other hand with the cultivation of transgenic plants (Grenelle in 2007, Citizens' Conference in 1998, Economic and Social Council in 2002, debates with members of parliament -French and European- and experts, the General Planning Commission, the Economic Analysis Council, conferences in various places in France and elsewhere -Italy, Ukraine, Romania, Tunisia, Denmark, Canada, USA, Japan, Ecuador, Bolivia...-interviews...). He belongs or has belonged to various national committees related to Science in Society issues (CNL, Biovigilance, Biomolecular Engineering Commission, Sustainable Development, Grenelle de l'EnvironnementHigh Authority on GMOsScientific Council of CRIIGENVice President of Vivagora...) and was the rapporteur for Group 1 (Research & Society) to national research conferences from 2004. He chairs the Scientific Council of the Think-Tank of the Nicolas Hulot Foundation

He is a Knight of the Legion of Honour and of the Palmes Académiques.
He was awarded the American Society of Ecology's 2013 " William Skinner Cooper Award"He was awarded the "Grand Prix" by the French Society of Ecology in 2016 for the whole of his research work and for his involvement in questions of the relationship between science and society. He received the Radio France "Lire dans le noir" prize for his CD on evolution.




Join a community mobilised around the major challenges of the 21st century and united by a deep desire for reinvention, a thirst for imagination and a desire for action.

A space for exchanging, deciphering, imagining and creating desirable futures.

Created in 2015, ENGAGE is now structured around two activities:

  • ENGAGE Action launches Citizen Challenges around the major issues of the 21st century
  • ENGAGE University offers programmes around the fundamental knowledge, skills and tools to become a transformational pioneer. In particular, it hosts the Explorers of our Challenges.

ENGAGE opened in 2019 its campus, Bright City, which hosts our multidisciplinary community, conferences and workshops but also projects in fields as diverse as environment, education, AI, information, health.



The fundamental ambition of the Biodiversity Challenge is to put the economy back at the service of life.

Like the other Citizen Challenges developed by ENGAGE, it is the result of joint work between citizens, companies, associations, NGOs and the media.

The Challenge is now embodied in two projects that will take place during 2020:

  • Supporting 5 companies in their transformation into biodiversity allies

  • Launch a campaign to raise awareness of biodiversity issues in the economic and business spheres



Contacts for the Biodiversity Challenge :

Quentin Thomas, Challenges Officer, 06 08 00 41 24,

Laetitia Pfeffer, 06 82 25 30 50,



A living material that produces light

We are developing a bioluminescent raw material made from natural and infinitely cultivable micro-organisms. Our core business is biotechnology. We improve (without genetic modification) these micro-organisms to make them more efficient in terms of light production (intensity, stability, efficiency).

Sustainable light systems for the landscape of tomorrow

In collaboration with energy companies, real estate groups, architects, local authorities, artists, construction companies, landscapers and hotels, Glowee meets your sustainable lighting needs.

Let's create together the uses of bioluminescence of tomorrow!


Videos :

The board Biomim'review :


Releases :

Ministry of Agriculture / 14 NOV 2018 / Glowee: producing light without electricity

Les Echos / 03 SEPT 2019 / Crowdfunding: how Glowee raised over €1.3 million

FUTURA PLANET / 17 MAY 2017 / Bioluminescence: Introducing Glowee, an electricity-free biological light

LABIOTECH / 20 NOV 2019 / 39M Series B to Fund Biopolymers for Surgery and Implants

other news




CorWave develops innovative implantable cardiac pumps based on a breakthrough technology: the undulating membrane.

The CorWave corrugated membrane offers a novel approach in cardiac assist to provide true pulsatile blood flow.

CorWave is a fast-growing medical device company that develops novel cardiac assist pumps to provide reliable and sustainable solution to the major public health issue ofheart failure. The solutions developed by CorWave, which are truly physiological, will ensure better life to patients.

Founded in 2011 by the incubator MD Start and supported by renowned investors, CorWave has obtained over €35 million in funding and employs more than 50 employees.

CorWave has won numerous awards and competitions. In 2016 CorWave won phase 1 of the Global Innovation Contest (GIC) for the NovaPulse project. In 2017, this project also won phase 2 of the CMI competition. The same year, CorWave received the Deloitte Technology Fast 50 Biotech of the Future award, and in 2018 received support for the Calypso programme under the Programme d'Investissements d'Avenir (PIA) operated by Bpifrance.

Videos :

News and press review :

L'USINE NOUVELLE / 14 APR 2018 / CorWave develops innovative cardiac assist technology

LA TRIBUNE / 14 MAY 2019 / Public Choice Award 2018, CorWave accelerates towards clinical trials

CHALLENGES / 08 NOV 2016 / CorWave, an exciting fundraising

... more





M2i Life Sciences is an industrial player in the chemical industry, active in the animal and plant bio-control sector as well as in the field of human health. Biocontrol is the set of biological protection methods that replicate intra-species behaviours and natural mechanisms of regulation of bio-aggressors.

M2i Life Sciences is a world leader in pheromones for crop protection and animal health.

We master :

  • The synthesis of pheromonal molecules
  • The production of these pheromones from gram to ton
  • The formulation of these pheromones and the delivery systems
  • Design and production of finished products

We combine R&D know-how, a production plant and a manufacturing centre for finished products, which allows us to control the entire product development cycle and to integrate innovation at every stage of its design.

The intervention of Johann Fournil at Biomim'expo 2019 :

The board Biomim'review :

Releases :

ActuLot / 27 JUNE 2020 / In Parnac, M2i launches a unique production for biological crop protection

INFO CHEMISTRY / 31 MAR 2020 / Exclusive interview with Philippe Guerret, President of M2i Life Sciences

The Tribune / 09 SEP 2019 / M2i, French biocontrol expert, raises €60 million

USINE NOUVELLE / 03 SEP 2019 / M2i Life Sciences raises €60 million to support its strong growth in AgTech

Chemistry News / 04 SEP 2019 / Biocontrol: French company M2i raises €60 million

L'USINE NOUVELLE / 5 NOV 2019 / M2i Life Sciences named Start-up of the Year 2019 by L'Usine Nouvelle



  • M2i Life Sciences
    1, rue royale
    112 Hill Offices Building G1 - Ground Floor 1
    92 213 Saint-Cloud Cedex
  • tel-icon+33 1 85 74 09 29



TISSIUM™ invents the next generation of synthetic polymers for tissue reconstruction :

  • BIOMORPHIC : Conforms to and integrates with surrounding tissue to enable natural healing
  • PROGRAMMABLE : Modular polymer design can be adjusted to match tissue-specific requirements

TISSIUM was founded in 2013 to address one of the most persistent medical challenges since the inception of surgical procedures: to reconstruct damaged tissue and restore its natural function.

Since the discovery of our first polymer at the labs of Bob Langer and Jeff Karp at MIT, we recognized the exceptional potential for our technology to revolutionize the field of tissue reconstruction in multiple therapeutic areas.

Our unique approach to product development leverages the knowledge gained from the development of our technology platform comprised of proprietary polymers, activation technologies, and delivery devices.

We have developed a fully integrated innovation, design, commercialisation and manufacturing platform to support our internal programmes as well as co-development partnerships with leaders in the medtech industry.

Maria Pereira's intervention at Biomim'expo 2019:

The board Biomim'review :


Releases :

Les Echos / 20 NOV 2019 / Tissium raises €39 million for its programmable surgical polymers

BFM BUSINESS / 21 NOV 2019 / French start-up Tissium, which wants to repair human tissue, raises €39 million

SOFINNOVA / 20 NOV 2019 / TISSIUM Closes €39M Series B Funding Round

LABIOTECH / 20 NOV 2019 / 39M Series B to Fund Biopolymers for Surgery and Implants

other news